Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Molecular Pharmaceutics|February 23, 2012
Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imagingTanja Ouimet, Eric Lancelot, Fabien Hyafil, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 21, 2025
Assessment of sestamibi CZT-SPECT reconstructed using deep-learning-based virtual attenuation correction maps according to coronary artery territory and with comparison to rubidium-PETTelma Sprauel, Laetitia Imbert, Kaya Doyeux, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 28, 2008
Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRIJean-Christophe Cornily, Fabien Hyafil, Claudia Calcagno, et al.
Journal of the American College of Cardiology|February 2, 2010
Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantationDavid Messika-Zeitoun, Jean-Michel Serfaty, Eric Brochet, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular DiseaseMatthieu Bailly, Anne Claire Dupont, Guillaume Domain, et al.
Coronary Artery Disease|May 14, 2024
Prevalence and location of coronary artery disease in anomalous aortic origin of coronary arteriesSandra Zendjebil, Athanasios Koutsoukis, Thomas Rodier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2024
Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESCFederico Caobelli, Marc R Dweck, Domenico Albano, et al.
Pageof 12